As the next step, it will be interesting to understand whether the expression level of miR-124 is different in different stages of HNSCC and whether the altered expression of miR-124 is associated with the development of HNSCC resistance to chemotherapy, EGFR inhibition, and other therapies. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.